(Q46421419)

English

Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients

scientific article

Statements

Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit